Our Pricing

Mounjaro 10mg UK - Compare Lowest Prices Here

Searching for mounjaro 10mg uk lowest price options with transparent, upfront costs? Cured Pharmacy offers genuine UK-licensed Mounjaro 10mg KwikPens from £135.00 with free clinical assessment by UK prescribers and discreet next-day delivery. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription meets MHRA standards, so you receive authentic tirzepatide at competitive UK pricing without hidden fees.

How Mounjaro 10mg Works for Weight Loss

Mounjaro 10mg contains tirzepatide, the UK's first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced effects on appetite regulation, insulin secretion, and energy expenditure.

In the SURMOUNT-1 clinical trial, participants receiving tirzepatide 10mg achieved an average body weight reduction of 19.5% over 72 weeks, compared to 3.1% with placebo [1]. This dual-receptor mechanism explains why patients often report earlier satiety, reduced food cravings, and sustained weight loss when compared to older GLP-1-only therapies [2].

The 10mg dose represents the mid-range maintenance strength in the Mounjaro titration schedule. UK prescribers typically initiate treatment at 2.5mg, increasing every four weeks through 5mg, 7.5mg, and 10mg doses based on individual tolerability and clinical response [3]. Some patients may progress to 12.5mg or 15mg if additional weight reduction is clinically appropriate, subject to prescriber approval.

Mounjaro 10mg UK Price Comparison: What You Should Know

Price transparency remains a significant challenge when comparing mounjaro 10mg uk options across online pharmacies. At Cured Pharmacy, Mounjaro 10mg is available from £135.00 per four-week supply, with pricing displayed upfront before your free consultation begins—no hidden consultation fees or subscription traps.

Many UK pharmacies advertise starting prices based on lower initiation doses (2.5mg or 5mg), which creates misleading price comparisons. The 10mg maintenance dose typically costs more per pen than starter doses, so verifying the specific strength you're comparing is essential. Our pricing structure covers the complete service: UK prescriber assessment, genuine Mounjaro KwikPen, and discreet delivery to your door.

Beware of unusually low advertised prices that exclude mandatory consultation fees, delivery charges, or require long-term subscriptions. Under UK pharmaceutical regulations, all Mounjaro prescriptions require clinical assessment by a GPhC-registered prescriber, and legitimate pharmacies must factor these professional services into transparent pricing [4].

Understanding Mounjaro Dosing Costs Over Time

Your total treatment cost depends on your prescribed titration schedule. Most patients begin at 2.5mg for four weeks, then progress through 5mg and 7.5mg before reaching the 10mg maintenance dose at week 12. Your UK prescriber will determine the optimal dose escalation based on your weight loss response, tolerability, and clinical goals during ongoing consultations.

Mounjaro 10mg vs Wegovy: Clinical Differences Explained

Both Mounjaro and Wegovy are injectable weight loss treatments licensed by the MHRA, but they operate through distinct pharmacological pathways. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro's tirzepatide activates both GIP and GLP-1 receptors—a dual mechanism that often produces greater weight reduction in head-to-head comparisons [5].

In the SURPASS-2 trial, tirzepatide 10mg demonstrated superior weight loss compared to semaglutide 1mg (the active dose in Wegovy), with participants losing an average of 10.3kg versus 5.7kg over 40 weeks [5]. This enhanced efficacy comes from GIP's additional effects on fat metabolism and energy expenditure, complementing GLP-1's appetite suppression.

Choosing between Mounjaro 10mg and Wegovy depends on individual factors including previous treatment response, side effect profile, and clinical suitability. Some patients tolerate one medication better than the other, whilst cost considerations and supply availability also influence prescriber recommendations. Your UK clinical assessment will evaluate which treatment aligns with your medical history and weight management goals.

Side Effect Profiles: What to Expect

Both medications share common gastrointestinal side effects—nausea, diarrhoea, constipation, and vomiting—particularly during dose escalation [1][5]. These effects typically diminish after several weeks as your body adjusts. Slower titration schedules and taking injections with food can help minimise discomfort. Always report persistent or severe side effects to your prescriber, who may adjust your dose or recommend an alternative treatment.

How to Buy Mounjaro 10mg Online UK Safely

Purchasing Mounjaro 10mg online in the UK requires completing a clinical assessment with a GPhC-registered prescriber—there are no legal shortcuts. At Cured Pharmacy, the process takes under three minutes: complete our online health questionnaire, receive prescriber review within hours, and if approved, your genuine Mounjaro KwikPen ships discreetly from our UK-registered pharmacy (GPhC 9012511).

Verify any online pharmacy's credentials before sharing medical information or payment details. Legitimate UK pharmacies display their GPhC registration number prominently, employ named superintendent pharmacists, and never offer prescription-only medicines without clinical assessment. Counterfeit tirzepatide products circulating online may contain incorrect doses, contaminants, or no active ingredient—posing serious health risks [6].

Red flags include websites offering Mounjaro without prescription, prices significantly below market rates, overseas shipping from non-EU countries, or unclear pharmacy registration details. The MHRA and GPhC maintain public registers where you can verify a pharmacy's legitimacy before placing orders. Protecting your health and data starts with choosing properly regulated providers.

Mounjaro 10mg Dosing Schedule and Administration

Mounjaro 10mg is administered as a once-weekly subcutaneous injection, typically into the abdomen, thigh, or upper arm. Each KwikPen contains four pre-filled doses, providing a month's supply when injecting weekly on the same day (e.g., every Monday). The pen's simple click-mechanism requires no manual measurement—patients simply attach a new needle, dial the dose, and inject [7].

Most UK prescribers follow a structured titration protocol: starting at 2.5mg weekly for four weeks, then increasing to 5mg, 7.5mg, and 10mg at four-week intervals if tolerated. This gradual escalation minimises gastrointestinal side effects whilst allowing your body to adapt to tirzepatide's metabolic effects [3]. Some patients remain on 10mg long-term, whilst others progress to 12.5mg or 15mg based on clinical response.

Inject Mounjaro on the same day each week, but if you miss a dose, administer it within four days of the scheduled day. If more than four days have passed, skip that dose and resume your regular schedule—never double up to compensate. Rotate injection sites weekly to reduce the risk of lipodystrophy (skin changes at injection sites). Store unused pens in the refrigerator between 2°C and 8°C, and never freeze [7].

Managing Common Injection Site Reactions

Mild redness, itching, or swelling at injection sites affects some patients but usually resolves within days. Ensure the pen reaches room temperature before injecting, clean the site with an alcohol wipe, and apply gentle pressure (without rubbing) after injection. Persistent lumps, severe pain, or signs of infection warrant immediate prescriber contact.

Who Can Use Mounjaro 10mg in the UK?

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [8]. UK prescribers assess eligibility during your online consultation, reviewing your medical history, current medications, and weight management goals.

Mounjaro is contraindicated in patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. It's not recommended during pregnancy or breastfeeding, and women of childbearing potential should use reliable contraception during treatment [8]. Your prescriber will screen for these conditions before approving a prescription.

Patients taking insulin or sulfonylureas may require dose adjustments to avoid hypoglycaemia when starting Mounjaro, as tirzepatide enhances insulin secretion. Those with diabetic retinopathy should be monitored closely due to rapid glucose improvements potentially worsening eye conditions temporarily [3]. Full medical disclosure during your consultation ensures safe, personalised prescribing aligned with MHRA guidance.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., Brown, K. D., SURPASS-2 Investigators. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
3. Electronic Medicines Compendium (eMC). (2023). Mounjaro 10 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). https://www.medicines.org.uk/emc/product/14553/smpc
4. General Pharmaceutical Council (GPhC). (2023). Standards for registered pharmacies. https://www.pharmacyregulation.org/standards/standards-registered-pharmacies
5. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., Brown, K. D., SURPASS-2 Investigators. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
6. Medicines and Healthcare products Regulatory Agency (MHRA). (2023). Falsified medical products strategy 2023-2028. https://www.gov.uk/government/publications/falsified-medical-products-strategy
7. Eli Lilly and Company. (2023). Mounjaro (tirzepatide) injection: Instructions for Use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
8. National Institute for Health and Care Excellence (NICE). (2023). Tirzepatide for treating overweight and obesity [ID6218]. Technology appraisal guidance in development. https://www.nice.org.uk/guidance/indevelopment/gid-ta11211

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, lifestyle modifications, and individual metabolic factors.